CVS Health Corporation (CVS)
Largest Insider Buys in Sector
CVS Stock Price History Chart
CVS Stock Performance
About CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary …
Insider Activity of CVS Health Corporation
Over the last 12 months, insiders at CVS Health Corporation have bought $554,173 and sold $2.27M worth of CVS Health Corporation stock.
On average, over the past 5 years, insiders at CVS Health Corporation have bought $663,639 and sold $53.15M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mahoney Michael F (director) — $1M. LUDWIG EDWARD J (director) — $215,516.
The last purchase of 9,181 shares for transaction amount of $500,294 was made by Mahoney Michael F (director) on 2024‑05‑02.
List of Insider Buy and Sell Transactions, CVS Health Corporation
| 2024-05-02 | director | 1,000 <0.0001% | $53.88 | $53,879 | +5.28% | |||
| 2024-05-02 | director | 9,181 0.0007% | $54.49 | $500,294 | +5.28% | |||
| 2024-02-16 | Sale | EVP and Pres-Pharm, Consumer W | 29,473 0.0023% | $76.95 | $2.27M | -22.19% | ||
| 2023-11-03 | director | 2,000 0.0002% | $70.47 | $140,930 | -3.01% | |||
| 2023-08-03 | Sale | SVP, Cont & Chief Acct Officer | 25,759.26 0.002% | $74.92 | $1.93M | -5.49% | ||
| 2023-05-03 | President and CEO | 14,000 0.0011% | $69.75 | $976,567 | +2.03% | |||
| 2022-12-15 | Sale | EVP & General Counsel | 36,490 0.0028% | $98.24 | $3.58M | -24.78% | ||
| 2022-08-03 | Sale | EVP&President-PharmacyServices | 70,398 0.0052% | $98.00 | $6.9M | -12.65% | ||
| 2022-08-03 | Sale | EVP/Pres, Health Care Benefits | 9,546 0.0007% | $100.00 | $954,600 | -12.65% | ||
| 2022-06-28 | Sale | EVP & General Counsel | 50,502 0.0039% | $95.00 | $4.8M | -1.21% | ||
| 2022-04-08 | Sale | EVP and Co-President of Retail | 5,719 0.0004% | $105.00 | $600,495 | -9.75% | ||
| 2022-04-04 | Sale | EVP/Pres, Health Care Benefits | 16,161 0.0012% | $100.13 | $1.62M | -3.64% | ||
| 2022-03-30 | Sale | EVP and Co-President of Retail | 5,346 0.0004% | $104.70 | $559,726 | -6.88% | ||
| 2022-03-17 | Sale | EVP and Co-President of Retail | 2,935 0.0002% | $106.65 | $313,018 | -10.72% | ||
| 2022-03-15 | Sale | EVP & General Counsel | 51,361 0.0038% | $105.00 | $5.39M | -9.33% | ||
| 2022-02-10 | director | 1,000 <0.0001% | $105.90 | $105,904 | -5.98% | |||
| 2022-02-03 | Sale | EVP and Chief Medical Officer | 47,937 0.0037% | $110.00 | $5.27M | -8.69% | ||
| 2022-02-01 | Sale | EVP&President-PharmacyServices | 21,386 0.0016% | $106.50 | $2.28M | -6.46% | ||
| 2022-01-28 | Sale | SVP, Cont & Chief Acct Officer | 6,059 0.0005% | $109.00 | $660,431 | -8.97% | ||
| 2022-01-27 | Sale | EVP & Chief Operating Officer | 68,482 0.0053% | $107.50 | $7.36M | -6.85% |
Insider Historical Profitability
| LUDWIG EDWARD J | director | 21630 0.0017% | $44.04 | 7 | 0 | +11.69% |
| Mahoney Michael F | director | 9356 0.0007% | $44.04 | 1 | 0 | |
| RYAN THOMAS M | Non-Executive Chairman | 764683 0.0608% | $44.04 | 2 | 20 | +6.97% |
| Moriarty Thomas M | EVP & General Counsel | 608129 0.0483% | $44.04 | 1 | 9 | +14.92% |
| Lynch Karen S | President and CEO | 431392 0.0343% | $44.04 | 1 | 1 | +2.03% |
Institutional Investor Ownership
| The Vanguard Group | $9.26B | 9.25 | 116.12M | -1.34% | -$125.92M | 0.17 | |
| BlackRock | $6.95B | 6.94 | 87.1M | +0.09% | +$6.26M | 0.15 | |
| State Street | $4.39B | 4.38 | 55M | -0.36% | -$15.86M | 0.18 | |
| Capital World Investors | $3.49B | 3.49 | 43.78M | +7.97% | +$257.8M | 0.58 | |
| Dodge & Cox | $3.27B | 3.27 | 41.01M | +34.85% | +$845.39M | 1.9 |